Covid vaccine induced parkinsonism and cognitive dysfunction
Objective: To describe movement disorder and cognitive impairment in two patients following COVID-19 vaccination. Background: The manifestation of neurological complications have been increasingly evidenced following…Balance evaluation in Parkinson’s disease using a set of simple tests
Objective: The study aimed to evaluate balance using a proposed set of tests in people with Parkinson’s disease compared to healthy people. Background: Numerous balance…Impulse control disorder following bilateral pallidothalamic tract focused ultrasound: a case report
Objective: Description of a case of ICD following non-contemporaneous bilateral pallidothalamic focused ultrasound tractotomy. Background: Impulsive and compulsive behaviours in PD are hypothesized to largely…Compound heterozygous PANK2 variants in two unrelated kindreds with atypical PKAN
Objective: To describe two unrelated individuals with progressive, late-onset Pantothenate kinase-associated neurodegeneration (PKAN) and a common missense variant in the PANK2 gene Background: Neurodegeneration with Brain-Iron Accumulation…Changes in gait and mobility measures collected in daily living conditions, in different stages of Parkinson’s disease
Objective: To explore mobility measures collected in daily-living conditions in different stages of PD. Background: Gait and mobility impairments are considered a cardinal sign in…Clinicopathologic features of primary lateral sclerosis with TDP-43 presenting as atypical parkinsonism
Objective: To clarify clinicopathologic features of pathologically-confirmed primary lateral sclerosis (PLS). Background: PLS is a neurodegenerative disorder characterized by slowly progressive upper motor neuron signs…Non-motor symptom characteristics in patients with essential tremor
Objective: The objective of this study was to evaluate non-motor symptoms in essential tremor (ET) and compare those to healthy controls (HCs). Background: ET is…Exploratory analysis of the effect of delayed-start prasinezumab on motor sign progression measured with the Roche PD Mobile Application v2: PASADENA Phase II Parts 1 and 2
Objective: To determine whether the positive effects of prasinezumab on motor progression measured by Roche PD Mobile Application (PASADENA study Part 1; 0-52 weeks; NCT03100149)…Surgical outcomes in Rare Movement Disorders: A report of seventeen patients from India
Objective: To study the outcome of functional neurosurgery among patients with Rare movement disorders (RMDs). Background: RMDs throw remarkable challenges to their appropriate management particularly…Non-motor symptoms in de-novo adult-onset focal dystonia
Objective: To assess the prevalence of non-motor symptoms in untreated de-novo patients with cervical dystonia and blepharospasm. Background: Adult-onset focal dystonia is a movement disorder…
- « Previous Page
- 1
- …
- 120
- 121
- 122
- 123
- 124
- …
- 153
- Next Page »